Brief: Lisata Therapeutics Reports Third Quarter 2022 Financial Results And Provides Business Update
10/11/2022 22:03
Nov 10 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* LISATA THERAPEUTICS INC QTRLY LOSS PER SHARE $7.88
Source text for Eikon: ID:nGNX8HnM3V
Further company coverage: LSTA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal